March 16th, 2015
Better Than BEST? An Observational Comparison of PCI and CABG for Multivessel Coronary Disease
Sripal Bangalore, MD, MHA
Sripal Bangalore discusses his observational study comparing CABG with everolimus-eluting stent PCI in patients with multivessel coronary disease, alongside findings from the BEST randomized trial.
October 21st, 2013
Selections from Richard Lehman’s Literature Review: October 21st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include cholecalciferol to reduce BP in older patients with isolated systolic hypertension, the FREEDOM trial, and more.
NEJM Journal Watch — Recent Cardiology Articles- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Session 2024